CUV 1.03% $14.67 clinuvel pharmaceuticals limited

Comparing is one thing but we have had another extremely slow...

  1. 52 Posts.
    lightbulb Created with Sketch. 14
    Comparing is one thing but we have had another extremely slow newsflow this half year with cuv. I don't expect any news until the numbers come out iat the end of August. I hope they get close to 100mln AUD revenues.

    Especially on the xp/DNA repair trial the delay is horrendous. Just 6 patients and a handful of healthy participants. Same for AIS trials, the final results take ages. Did they lose the files or mess up the DNA samples?

    The OTC launch has suddenly been downgraded to a soft launch and a re-launch of the webshop. So what exactly do they wait for? Nobody can expect Cyacelle to break any sales records. There is enormous competition from trusted brands. To me it sounds as if they are scared to launch the products everyone is really waiting for.

    At least we have vitiligo phase 3 (pinch myself) ongoing and enough money to keep this show on the road for some years.
    Glta
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.